Analysis of publicly available breast cancer expression profiles revealed that high expression of both FGFR1 and HGF were associated with poor relapse-free survival (RFS) specifically in basal tumours (Fig. 8d, e). This evidence concerns the gene FGFR1 and breast carcinoma.